Pacific Biosciences of California Inc (PACB)
1.55
+0.09
(+6.16%)
USD |
NASDAQ |
Apr 19, 16:00
1.55
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Price: 1.55 for April 19, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 18, 2024 | 1.39 | 1.505 | 1.29 | 1.46 | 18.70M |
Apr 17, 2024 | 1.50 | 1.520 | 1.25 | 1.40 | 35.38M |
Apr 16, 2024 | 1.95 | 2.01 | 1.36 | 1.40 | 65.40M |
Apr 15, 2024 | 3.19 | 3.20 | 2.81 | 2.835 | 8.949M |
Apr 12, 2024 | 3.31 | 3.35 | 3.13 | 3.17 | 8.707M |
Apr 11, 2024 | 3.40 | 3.47 | 3.27 | 3.38 | 5.399M |
Apr 10, 2024 | 3.42 | 3.50 | 3.25 | 3.33 | 8.262M |
Apr 09, 2024 | 3.45 | 3.70 | 3.41 | 3.61 | 5.326M |
Apr 08, 2024 | 3.57 | 3.57 | 3.38 | 3.45 | 4.991M |
Apr 05, 2024 | 3.27 | 3.43 | 3.22 | 3.35 | 4.746M |
Apr 04, 2024 | 3.42 | 3.64 | 3.29 | 3.33 | 5.801M |
Apr 03, 2024 | 3.37 | 3.515 | 3.21 | 3.36 | 7.664M |
Apr 02, 2024 | 3.60 | 3.60 | 3.37 | 3.41 | 7.983M |
Apr 01, 2024 | 3.83 | 3.845 | 3.58 | 3.65 | 6.082M |
Mar 28, 2024 | 3.76 | 3.89 | 3.68 | 3.75 | 6.566M |
Mar 27, 2024 | 3.60 | 3.81 | 3.54 | 3.72 | 7.539M |
Mar 26, 2024 | 3.65 | 3.66 | 3.455 | 3.52 | 6.475M |
Mar 25, 2024 | 3.81 | 3.81 | 3.57 | 3.61 | 4.328M |
Mar 22, 2024 | 3.79 | 3.84 | 3.66 | 3.68 | 5.733M |
Mar 21, 2024 | 3.91 | 4.10 | 3.79 | 3.84 | 6.826M |
Mar 20, 2024 | 3.60 | 3.92 | 3.56 | 3.82 | 6.381M |
Mar 19, 2024 | 3.65 | 3.855 | 3.535 | 3.64 | 11.99M |
Mar 18, 2024 | 3.83 | 3.830 | 3.63 | 3.67 | 4.732M |
Mar 15, 2024 | 3.90 | 3.98 | 3.73 | 3.79 | 6.658M |
Mar 14, 2024 | 4.20 | 4.229 | 3.86 | 3.91 | 11.89M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.40
Minimum
Apr 16 2024
51.15
Maximum
Feb 11 2021
12.20
Average
8.48
Median
Nov 30 2023
Price Benchmarks
Cerus Corp | 1.68 |
Axogen Inc | 6.46 |
AVITA Medical Inc | 8.63 |
BioSig Technologies Inc | 1.41 |
Intellia Therapeutics Inc | 21.57 |
Price Related Metrics
PS Ratio | 1.960 |
Price to Book Value | 0.5922 |
Earnings Yield | -78.06% |
Market Cap | 415.33M |